One clinical study of Hepatocellular carcinoma (HCC) showed that a surveillance program consisting of measurements of AFP levels and a liver ultrasound performed every 6 months resulted in a 37% reduction in mortality7. The gene discussed is AFP; the disease is hepatocellular carcinoma.